The CLDN18.2-targeting asset is currently under priority review by China’s NMPA, which could see it join the country’s ...
Dubbed “the next frontier of cancer prevention and care,” the microbiome appears to be especially critical when it comes to ...
The U.S. Food and Drug Administration has approved Hepcludex (bulevirtide‐gmod) injection to treat chronic hepatitis delta ...
Studies of obinutuzumab, a type II anti-CD20 antibody, have shown efficacy in the treatment of hematologic cancers and autoimmune diseases. An evaluation of the efficacy and safety of obinutuzumab in ...
Dr Daneng Li discusses promising research on hepatobiliary malignancies and HCC treatment presented at ASCO 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results